Literature DB >> 28602354

Head and Neck Cancer Pain.

Jakun W Ing1.   

Abstract

Pain is a significant morbidity resulting from head and neck cancer. Pain may also be the result of the treatments directed against head and neck cancer. An experienced practitioner may manage this pain by understanding the multifactorial mechanisms of pain and the various pharmacotherapies available. Pain should be managed with multiple medications in a multimodal approach, and nonpharmacologic therapies should be considered as well.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute postsurgical pain; Head and neck cancer pain; Mucositis; Multimodal therapy; Neuropathic pain; Opioid management

Mesh：

Substances：

Year:  2017        PMID： 28602354     DOI： 10.1016/j.otc.2017.04.001

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN： 0030-6665            Impact factor:   3.346


  6 in total

1.  Opioid Prescription Patterns Among Patients With Head and Neck Cancer.

Authors:  Rosh K V Sethi; Neelima Panth; Sidharth V Puram; Mark A Varvares
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-04-01       Impact factor: 6.223

2.  Risk of Chronic Opioid Use After Radiation for Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Sondos Zayed; Cindy Lin; R Gabriel Boldt; Jinka Sathya; Varagur Venkatesan; Nancy Read; Lucas C Mendez; Dwight E Moulin; David A Palma
Journal:  Adv Radiat Oncol       Date:  2020-10-26

Review 3.  Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis.

Authors:  Herve Y Sroussi; Joel B Epstein; Rene-Jean Bensadoun; Deborah P Saunders; Rajesh V Lalla; Cesar A Migliorati; Natalie Heaivilin; Zachary S Zumsteg
Journal:  Cancer Med       Date:  2017-10-25       Impact factor: 4.452

Review 4.  Quality Assessment in Supportive Care in Head and Neck Cancer.

Authors:  Pierluigi Bonomo; Alberto Paderno; Davide Mattavelli; Sadamoto Zenda; Stefano Cavalieri; Paolo Bossi
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244

Review 5.  Opioids in cancer: The κ‑opioid receptor (Review).

Authors:  Qier Zhou; Zhiwei Zhang; Songkai Long; Wanjun Li; Baiyun Wang; Na Liang
Journal:  Mol Med Rep       Date:  2021-12-08       Impact factor: 2.952

6.  Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors.

Authors:  Jenny L Ren; Raniv D Rojo; Joy Vanessa D Perez; Sai-Ching J Yeung; Ehab Y Hanna; Cielito C Reyes-Gibby
Journal:  BMC Cancer       Date:  2021-12-06       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.